Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer
- DOI
- 10.1002/jcph.70001
- Published
- 2025-02-19
- Container
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/jcph.70001,
title = {Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer},
author = {Xiaofei Zhou and Xiaoyan Yang and Boris Grinshpun and Adekemi Taylor and Laura Strong and Arvind Dasari and Andrea Wang‐Gillam and Jin Li and Rui‐Hua Xu and Neeraj Gupta and Caly Chien},
year = {2025},
journal = {The Journal of Clinical Pharmacology},
doi = {10.1002/jcph.70001},
url = {https://doi.org/10.1002/jcph.70001}
}RIS
TY - JOUR TI - Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer AU - Xiaofei Zhou AU - Xiaoyan Yang AU - Boris Grinshpun AU - Adekemi Taylor AU - Laura Strong AU - Arvind Dasari AU - Andrea Wang‐Gillam AU - Jin Li AU - Rui‐Hua Xu AU - Neeraj Gupta AU - Caly Chien PY - 2025 JO - The Journal of Clinical Pharmacology DO - 10.1002/jcph.70001 UR - https://doi.org/10.1002/jcph.70001 ER -
APA
Zhou, X., Yang, X., Grinshpun, B., Taylor, A., Strong, L., Dasari, A., Wang‐Gillam, A., Li, J., Xu, R., Gupta, N., & Chien, C. (2025). Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR ‐1, ‐2, and ‐3, in Patients with Refractory Metastatic Colorectal Cancer. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70001
Source records
- crossref · retrieved 2026-09-27T03:34:46.104Z